Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Kendle | Contract Pharma
Breaking News, Promotions & Moves

Kendle

Dr. Ross J. Horsburgh has been appointed vice president of global clinical development Asia/Pacific, Kendle. In this role, he will lead the company’s overall expansion in this region and provide strategic oversight for its Phase II-III operations, including Melbourne and Sydney, Australia; New Delhi, India; and Beijing, China.
   
“With a population base of nearly 4 billion and R&D spending expected to reach $20 billion by 2013, Asia/Pacific is recognized by our customers as one of the more dynamic regions in which to conduct clinical trials,” said chairman and chief executive officr Dr. Candace Kendle. “Dr. Horsburgh’s extensive clinical development experience and familiarity with the Asia/Pacific region will benefit both our customers and Kendle as we execute on our growth strategy for this pivotal market.”
   
Dr. Horsburgh has 20 years of CRO and pharmaceutical industry experience. Prior to joining the company, he was regional medical director, Asia Pacific for AstraZeneca, where he assembled and led a team of 200 across 13 markets. He also served as head of AZ’s internal clinical research organization, responsible for quality assurance, drug safety, talent management and development, input of the Asian view into global product design, and submissions to the FDA and EMA. Dr. Horsburgh also held positions with Ciba and the Auckland Hospital Board.  
   
Dr. Horsburgh will report directly to Dr. Kendle for Asia/Pacific expansion and to Martha Feller, Ph.D., senior vice president, global clinical development for Phase II-III operations. He will be based in Singapore.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters